Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2200862 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Jordan M Dailey und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Anaphylaxis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
IgE-mediated mast cell activation is a driving force in allergic disease in need of novel interventions. Statins, long used to lower serum cholesterol, have been shown in multiple large-cohort studies to reduce asthma severity. We previously found that statins inhibit IgE-induced mast cell function, but these effects varied widely among mouse strains and human donors, likely due to the upregulation of the statin target, 3-hydroxy-3-methylgutaryl-CoA reductase. Statin inhibition of mast cell function appeared to be mediated not by cholesterol reduction but by suppressing protein isoprenylation events that use cholesterol pathway intermediates. Therefore, we sought to circumvent statin resistance by targeting isoprenylation. Using genetic depletion of the isoprenylation enzymes farnesyltransferase and geranylgeranyl transferase 1 or their substrate K-Ras, we show a significant reduction in FcεRI-mediated degranulation and cytokine production. Furthermore, similar effects were observed with pharmacological inhibition with the dual farnesyltransferase and geranylgeranyl transferase 1 inhibitor FGTI-2734. Our data indicate that both transferases must be inhibited to reduce mast cell function and that K-Ras is a critical isoprenylation target. Importantly, FGTI-2734 was effective in vivo, suppressing mast cell–dependent anaphylaxis, allergic pulmonary inflammation, and airway hyperresponsiveness. Collectively, these findings suggest that K-Ras is among the isoprenylation substrates critical for FcεRI-induced mast cell function and reveal isoprenylation as a new means of targeting allergic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA.
- Department of Biology, Virginia Commonwealth University, Richmond, VA.
- Department of Pharmacology and Toxicology, and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA.
- Department of Pathology, University of Utah, Salt Lake City, UT.
- Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA.
ORCID-Profile: Elizabeth Motunrayo Kolawole, Quang T Le, Lawrence B Schwartz, David B Straus, Rebecca K Martin
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
- Foundation for the National Institutes of Health
Zitieren
APA
Dailey, J. M., Kee, S. A., Tharakan, A., Kazi, A., Burchett, J. R., Kolawole, E. M., Boyd Ballance, W., Kotha, A., Le, Q. T., Schwartz, L. B., Straus, D. B., Martin, R. K., Sebti, S. M., & Ryan, J. J. (2023). Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200862
Vancouver
Dailey JM, Kee SA, Tharakan A, Kazi A, Burchett JR, Kolawole EM, et al. Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200862
BibTeX
@article{Dailey2023,
author = {Dailey, Jordan M and Kee, Sydney A and Tharakan, Anuj and Kazi, Aslamuzzaman and Burchett, Jason R and Kolawole, Elizabeth Motunrayo and Boyd Ballance, William and Kotha, Aditya and Le, Quang T and Schwartz, Lawrence B and Straus, David B and Martin, Rebecca K and Sebti, Said M and Ryan, John J},
title = {Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2200862}
}
EUVIMED